Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bongin Yoo

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Pharmaceutical Statistics|May 2, 2009
Impact of missing data on type 1 error rates in non-inferiority trialsBongin Yoo
Pharmaceutical Statistics|November 12, 2009
The impact of dichotomization in longitudinal data analysis: a simulation studyBongin Yoo
Lifetime Data Analysis|September 1, 2005
Linear signed-rank tests for paired survival data subject to a common censoring timeMichael P Jones, Bongin Yoo
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 10, 2021
Omalizumab response in patients with asthma by number and type of allergenWeily Soong, Bongin Yoo, Hooman Pazwash, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 6, 2006
Blood pressure as an independent prognostic factor in acute ischemic strokeMatt B Jensen, Bongin Yoo, William R Clarke, et al.
American Journal of Rhinology & Allergy|August 12, 2021
Defining the Efficacy of Omalizumab in Nasal Polyposis: A POLYP 1 and POLYP 2 Subgroup AnalysisCecelia Damask, Meng Chen, Cecile T J Holweg, et al.
Drugs - Real World Outcomes|January 8, 2017
HER2-Positive Metastatic Breast Cancer Patients Receiving Pertuzumab in a Community Oncology Practice Setting: Treatment Patterns and OutcomesNicholas J Robert, Hans-Peter Goertz, Pooja Chopra, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 17, 2020
Treatment Benefit with Omalizumab in Children by Indicators of Asthma SeverityStanley J Szefler, Thomas B Casale, Tmirah Haselkorn, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 24, 2021
Response to Omalizumab in Black and White Patients with Allergic AsthmaStanley J Szefler, Elina Jerschow, Bongin Yoo, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 19, 2021
No difference in omalizumab efficacy in patients with asthma by number of asthma-related and allergic comorbiditiesMeng Chen, Eugene Choo, Bongin Yoo, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Pharmaceutical Statistics|May 2, 2009
Impact of missing data on type 1 error rates in non-inferiority trialsBongin Yoo
Pharmaceutical Statistics|November 12, 2009
The impact of dichotomization in longitudinal data analysis: a simulation studyBongin Yoo
Lifetime Data Analysis|September 1, 2005
Linear signed-rank tests for paired survival data subject to a common censoring timeMichael P Jones, Bongin Yoo
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 10, 2021
Omalizumab response in patients with asthma by number and type of allergenWeily Soong, Bongin Yoo, Hooman Pazwash, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 6, 2006
Blood pressure as an independent prognostic factor in acute ischemic strokeMatt B Jensen, Bongin Yoo, William R Clarke, et al.
American Journal of Rhinology & Allergy|August 12, 2021
Defining the Efficacy of Omalizumab in Nasal Polyposis: A POLYP 1 and POLYP 2 Subgroup AnalysisCecelia Damask, Meng Chen, Cecile T J Holweg, et al.
Drugs - Real World Outcomes|January 8, 2017
HER2-Positive Metastatic Breast Cancer Patients Receiving Pertuzumab in a Community Oncology Practice Setting: Treatment Patterns and OutcomesNicholas J Robert, Hans-Peter Goertz, Pooja Chopra, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 17, 2020
Treatment Benefit with Omalizumab in Children by Indicators of Asthma SeverityStanley J Szefler, Thomas B Casale, Tmirah Haselkorn, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 24, 2021
Response to Omalizumab in Black and White Patients with Allergic AsthmaStanley J Szefler, Elina Jerschow, Bongin Yoo, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 19, 2021
No difference in omalizumab efficacy in patients with asthma by number of asthma-related and allergic comorbiditiesMeng Chen, Eugene Choo, Bongin Yoo, et al.
Pageof 3